Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Neurology

Subspecialties Neurology

By the Numbers: Epilepsy and Neurodevelopmental Disorders

| Michael Schubert

Breaking down epilepsy and other neurodevelopmental disorders – the causes, the genetics, and those involved with diagnosis

Subspecialties Neurology

Predicting Prognosis in Glioblastoma

| Luke Turner

A link between cfDNA concentration and progression-free survival in glioblastoma patients supports the use of liquid biopsy when predicting prognosis

Outside the Lab Profession

The Truth Seeker

| Luke Turner

As the first to discover chronic traumatic encephalopathy, Bennet Omalu reflects on his career in forensic pathology and how he coped with criticism

Diagnostics Genetics and epigenetics

Exploring the Epi-signature

| Luke Turner

New research shows that genome-wide testing of DNA methylation can diagnose previously unsolved cases of neurodevelopmental and congenital anomalies

Diagnostics Microscopy and imaging

FDISCO

| Jonathan James

A new tool in the pathologist’s arsenal might facilitate 3D imaging of tissues and organs

Subspecialties Clinical care

An Inside Look at the CNS

| Danielle Fortuna, Mark Curtis

Neurological disorders can be invasive and time-consuming to diagnose, but profiling cytokines in the cerebrospinal fluid can lessen that burden

Diagnostics Analytical science

Biomarkers Beyond Our Wildest Dreams

| Luke Turner

Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease

Diagnostics Genetics and epigenetics

Biomarkers on the Brain

| Steve Clifford

A newly discovered chromosome signature offers hope to children with medulloblastoma who may not need intense therapy

Subspecialties Oncology

Quick Hits

| Luke Turner

Discover the latest in pathology and laboratory medicine with this roundup of short news stories

Subspecialties Biochemistry and molecular biology

Identifying Parkinson’s Inhibitors

| Luke Turner

An innovative approach aims to find the most effective inhibitors of α-synuclein protein aggregation, which is a leading cause of Parkinson’s disease


Sister Publications

You might be interested in our Sister Publications:

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register